Related Experiment Video
Updated: Aug 14, 2025

Underwater Endoscopic Injection Sclerotherapy for Gastroesophageal Varices
Published on: August 1, 2025
Bouveret Syndrome in a Cirrhotic Patient
Daniel T Gildea1, Dalal Alhaqqan2, Krystina Johnson2
1Internal Medicine, MedStar Georgetown University Hospital, Washington, D.C., USA.
Bouveret syndrome, a rare cause of gallstone impaction due to a chole-enteric fistula, presents challenges in cirrhotic patients. Management strategies for this rare condition require careful consideration due to high morbidity and mortality rates.
Area of Science:
- Gastroenterology and Hepatology
- Surgical Gastroenterology
Background:
- Bouveret syndrome is a rare condition characterized by gallstone impaction in the duodenum or stomach, often associated with a chole-enteric fistula.
- It predominantly affects elderly patients with significant comorbidities, leading to high rates of morbidity and mortality.
- The rarity and specific patient demographic for Bouveret syndrome mean there are no established diagnostic or management guidelines.
Observation:
- This case report details a patient with liver cirrhosis presenting with Bouveret syndrome.
- The patient had a chole-enteric fistula, a common underlying pathology for this syndrome.
- The clinical course highlights the challenges in managing this rare condition in a complex patient.
Findings:
- The case illustrates the diagnostic and therapeutic difficulties posed by Bouveret syndrome in patients with advanced liver disease.
- Management options for Bouveret syndrome are discussed in the context of the patient's comorbidities.
- The report emphasizes the need for individualized treatment approaches.
Implications:
- This case underscores the importance of considering Bouveret syndrome in patients with upper gastrointestinal obstruction and a history of gallstones, especially those with comorbidities.
- Further research into standardized management protocols for Bouveret syndrome in high-risk populations is warranted.
- Understanding the interplay between cirrhosis and Bouveret syndrome can improve patient outcomes.
Related Concept Videos
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Hepatic Portal System
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...

